These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prolactin levels in patients with systemic lupus erythematosus: a case controlled study. Jimena P; Aguirre MA; López-Curbelo A; de Andrés M; Garcia-Courtay C; Cuadrado MJ Lupus; 1998; 7(6):383-6. PubMed ID: 9736320 [TBL] [Abstract][Full Text] [Related]
23. Prolactin enhances the in vitro production of IgG in peripheral blood mononuclear cells from patients with systemic lupus erythematosus but not from healthy controls. Jacobi AM; Rohde W; Volk HD; Dörner T; Burmester GR; Hiepe F Ann Rheum Dis; 2001 Mar; 60(3):242-7. PubMed ID: 11171686 [TBL] [Abstract][Full Text] [Related]
24. Increased plasma/serum levels of prolactin in systemic lupus erythematosus: a systematic review and meta-analysis. Wang P; Lv TT; Guan SY; Li HM; Leng RX; Zou YF; Pan HF Postgrad Med; 2017 Jan; 129(1):126-132. PubMed ID: 27666289 [TBL] [Abstract][Full Text] [Related]
25. Systemic treatment of anti-CD4CD25 T cell monoclonal antibody exacerbates sialoadenitis in submandibular glands during the early life in lupus-prone female NZB x NZWF mice. Hayashi T; Adachi C; Hasegawa K J Oral Pathol Med; 2009 Feb; 38(2):234-40. PubMed ID: 19141059 [TBL] [Abstract][Full Text] [Related]
26. Involvement of postnatal gonads in the maturation of dopaminergic regulation of prolactin secretion in male rats. Watanobe H; Takebe K Endocrinology; 1987 Jun; 120(6):2205-11. PubMed ID: 3569130 [TBL] [Abstract][Full Text] [Related]
27. The effects of prolactin in animal models of SLE. Walker SE; Keisler D; Komatireddy GR; McMurray RW Scand J Rheumatol Suppl; 1998; 107():31-2. PubMed ID: 9759128 [No Abstract] [Full Text] [Related]
28. [Influence of serum prolactin on interleukin-6 secretion by peripheral blood mononuclear cells in patients with systemic lupus erythematosus]. Cai YT; Peng XB Nan Fang Yi Ke Da Xue Xue Bao; 2011 Sep; 31(9):1611-3. PubMed ID: 21945780 [TBL] [Abstract][Full Text] [Related]
29. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys. Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626 [TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor levels in a murine model of systemic lupus erythematosus. Athreya BH; Moore WC; Wadsworth SA; Gupta C; Goldman AS Clin Exp Rheumatol; 1989; 7(6):589-93. PubMed ID: 2612080 [TBL] [Abstract][Full Text] [Related]
32. Quantitative autoradiography of ligands for dopamine receptors and transporters in brain of Göttingen minipig: comparison with results in vivo. Minuzzi L; Olsen AK; Bender D; Arnfred S; Grant R; Danielsen EH; Cumming P Synapse; 2006 Mar; 59(4):211-9. PubMed ID: 16385509 [TBL] [Abstract][Full Text] [Related]
33. Prolactin receptors in dove brain: autoradiographic analysis of binding characteristics in discrete brain regions and accessibility to blood-borne prolactin. Buntin JD; Ruzycki E; Witebsky J Neuroendocrinology; 1993 Apr; 57(4):738-50. PubMed ID: 8367036 [TBL] [Abstract][Full Text] [Related]
34. Dopaminergic control of prolactin secretion in the turkey. Youngren OM; Pitts GR; Phillips RE; el Halawani ME Gen Comp Endocrinol; 1996 Nov; 104(2):225-30. PubMed ID: 8930613 [TBL] [Abstract][Full Text] [Related]
35. Dopaminergic receptors in human prolactin-secreting adenomas: a quantitative study. Bression D; Brandi AM; Martres MP; Nousbaum A; Cesselin F; Racadot J; Peillon F J Clin Endocrinol Metab; 1980 Nov; 51(5):1037-44. PubMed ID: 7419680 [TBL] [Abstract][Full Text] [Related]
36. Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment. Vera-Lastra O; Mendez C; Jara LJ; Cisneros M; Medina G; Ariza R; Espinoza LR J Rheumatol; 2003 Oct; 30(10):2140-6. PubMed ID: 14528507 [TBL] [Abstract][Full Text] [Related]
37. Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity. Leaños-Miranda A; Cárdenas-Mondragón G Rheumatology (Oxford); 2006 Jan; 45(1):97-101. PubMed ID: 16249247 [TBL] [Abstract][Full Text] [Related]
38. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32). Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887 [TBL] [Abstract][Full Text] [Related]
39. Histaminergic regulation of prolactin secretion: dose-response relationship and possible involvement of the dopaminergic system. Knigge U; Thuesen B; Christiansen PM J Clin Endocrinol Metab; 1986 Mar; 62(3):491-6. PubMed ID: 3944233 [TBL] [Abstract][Full Text] [Related]
40. Inhibitory effects of anti-prolactin receptor antibodies on prolactin binding in brain and prolactin-induced feeding behavior in ring doves. Li C; Kelly PA; Buntin JD Neuroendocrinology; 1995 Feb; 61(2):125-35. PubMed ID: 7753332 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]